-
Germline Genetic Testing Lags Behind Guidelines
Low rates of germline genetic testing in cancer patients means information that could affect treatment isn’t available.
by Jon Kelvey
-
Progress in Lung Cancer
November is Lung Cancer Awareness Month. Here are stories describing lung cancer treatment advances and the experiences of people who have been through a diagnosis.
-
Against All Odds
At age 26, Manny Garcia was diagnosed with and fought pancreatic cancer.
by Karon Warren
-
Finding the ‘Silent Killer’
Strange symptoms led cancer care nurse Eve Spiegel to an ovarian cancer diagnosis.
by Eve Spiegel
-
Seasonal Shot Strategies
Researchers find that patients with cancer who are severely immunocompromised may benefit from a more frequent seasonal vaccine schedule.
by Sandra Gordon
-
Increasing Diversity in Clinical Trials
Researchers share approaches for improving participation among underrepresented groups at AACR conference.
by Thomas Celona
-
Planning for the Return Home After Surgery
Experts suggest patients prepare for home recovery before surgery to help maintain some control.
by Coeli Carr
-
Making Treatment Decisions
It’s not always clear what to do when cancer progresses. Abigail Johnston shares how she has approached treatment decisions since her metastatic breast cancer diagnosis in 2017.
by Abigail M. Johnston
-
Fixing Systems, Building Trust
The AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved explores efforts needed to address inequities in care and outcomes.
by Eric Fitzsimmons
-
Accelerating and Improving Drug Discovery
Forum for patient advocates explores how researchers are working to develop cancer treatments in a quicker, more efficient manner.
by Thomas Celona
Cancer Talk
Researchers Tackle Immune-related Adverse Effects
Scientists present data on the risks of immune checkpoint inhibitors so more patients can tap into the treatment.
by Marci A. Landsmann
Tissue and Liquid Biopsy for Targeted TherapyTailored treatments led to better outcomes than standard of care when biomarker results from liquid biopsy and tumor tissue aligned.
by Eric Fitzsimmons
Cancer Vaccines Show Promise in Early TrialsWhile mRNA vaccines offer a personalized approach to triggering an immune response, peptide vaccines could be a one-size-fits-all treatment. Researchers are exploring both options.
by Thomas Celona
Declining Breast Cancer Mortality in Younger WomenU.S. breast cancer deaths declined for women ages 20 to 49, which researchers credit to wider screening and better treatment.
by Kevin McLaughlin